Chief Executive, Managing Director / NeuroScientific Biopharmaceuticals
Matthew Liddelow has over 12 years of experience in the commercialisation of biotechnology, medical devices and pharmaceuticals. Mr Liddelow has been involved in a number of startup companies including device company Medevco, which was acquired by Allied Healthcare Group (now Admedus). While employed by multi-national pharmaceutical company AstraZeneca, Mr Liddelow gained first-hand experience in the development, marketing and product launch of cardio vascular and respiratory related medications. In 2014, Mr Liddelow founded Enhanced Biomedical (deregistered in 2016), a medical device distribution business of which he was managing director.